MedTrace Logo

Pelvic Health Rehabilitation After Breast and Gynecologic Cancer

NCT06822582 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-02-12

No results posted yet for this study

Summary

The GYVE study aims at testing an online program (eModule) to help people who have had breast or gynecologic cancer and are experiencing pelvic health issues like urinary incontinence and pain during sex. These cancers and their treatments can cause significant pelvic health problems, affecting daily life and quality of life. Physiotherapy can help, but access is often limited due to costs and other barriers. The study will involve 20 participants from Quebec and Edmonton, who will take part in a 12-week program with weekly online group sessions led by a physiotherapist. Topics include pelvic floor muscle training, use of vaginal moisturizers, hydration, diet, and pain management. Led by experts in cancer rehabilitation and pelvic health, the study aims to provide valuable information on the feasibility and effectiveness of the eModule, potentially leading to broader implementation to help more people with lived experience of cancer.

Conditions

  • Gynecologic Cancers
  • Breast Cancer Female
  • Incontinence
  • Incontinence Bowel
  • Sexual Dysfunction
  • Vaginal Atrophy, Sexual Dysfunction, Vaginal Dryness, Dyspareunia
  • Constipation

Interventions

BEHAVIORAL

Pelvic Health Module

Telerehabilitation program involving pelvic floor exercises, education and counselling.

Sponsors & Collaborators

  • Laval University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-07
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06822582 on ClinicalTrials.gov